These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37038054)

  • 21. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
    Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
    Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.
    Wright GP; Perkins S; Jones H; Zureikat AH; Marsh JW; Holtzman MP; Zeh HJ; Bartlett DL; Pingpank JF
    Ann Surg Oncol; 2018 Jan; 25(1):83-90. PubMed ID: 29063296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review.
    Fruscione M; Pickens RC; Baker EH; Martinie JB; Iannitti DA; Hwang JJ; Vrochides D
    Curr Probl Cancer; 2021 Feb; 45(1):100614. PubMed ID: 32622478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current management of intrahepatic cholangiocarcinoma: from resection to palliative treatments.
    Bartolini I; Risaliti M; Fortuna L; Agostini C; Ringressi MN; Taddei A; Muiesan P
    Radiol Oncol; 2020 Jul; 54(3):263-271. PubMed ID: 32726292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
    Poggi G; Amatu A; Montagna B; Quaretti P; Minoia C; Sottani C; Villani L; Tagliaferri B; Sottotetti F; Rossi O; Pozzi E; Zappoli F; Riccardi A; Bernardo G
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1187-92. PubMed ID: 19727937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver resection and transplantation for intrahepatic cholangiocarcinoma.
    Mazzaferro V; Gorgen A; Roayaie S; Droz Dit Busset M; Sapisochin G
    J Hepatol; 2020 Feb; 72(2):364-377. PubMed ID: 31954498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A long term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment].
    Masuda T; Beppu T; Ishiko T; Mizumoto T; Hosaka S; Nakahara O; Hayashi H; Okabe H; Yamanaka T; Okabe K; Takamori H; Kanemitsu K; Hirota M; Baba H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1944-6. PubMed ID: 17212154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional options in the management of cholangiocarcinoma: single center experience.
    Baydoun H; Meirovich H; Maroun G; Coburn N; David E
    Ann Palliat Med; 2021 Feb; 10(2):1784-1791. PubMed ID: 33725764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.
    Seidensticker R; Ricke J; Seidensticker M
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):319-32. PubMed ID: 25966431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm].
    Lurje G; Bednarsch J; Roderburg C; Trautwein C; Neumann UP
    Chirurg; 2018 Nov; 89(11):858-864. PubMed ID: 30182267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study.
    Goerg F; Zimmermann M; Bruners P; Neumann U; Luedde T; Kuhl C
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1709-1717. PubMed ID: 31578633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
    Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
    Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locoregional Therapy for Intrahepatic Cholangiocarcinoma.
    Owen M; Makary MS; Beal EW
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
    Hong K; Geschwind JF
    Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.
    Moris D; Palta M; Kim C; Allen PJ; Morse MA; Lidsky ME
    CA Cancer J Clin; 2023 Mar; 73(2):198-222. PubMed ID: 36260350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma.
    Yuan P; Song J; Wang F; Zhu G; Chen B
    Invest New Drugs; 2022 Oct; 40(5):1125-1132. PubMed ID: 35793038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.